NCT01714973View on ClinicalTrials.gov

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Radiation-induced Dermatitis
Interventions
BIOLOGICAL

ST266

Patients will receive ST266 spray, to half the breast and saline to the other half (blinded) after each of ten consecutive radiation therapy treatments. ST266 and saline will be sprayed onto the breast to deliver 0.01 ml/cm2.

Trial Locations (1)

15212

Allegheny General Hospital, Pittsburgh

Sponsors
All Listed Sponsors
lead

Noveome Biotherapeutics, formerly Stemnion

INDUSTRY

NCT01714973 - Study of ST266 Versus Saline in Treating Skin Irritation From Radiation | Biotech Hunter | Biotech Hunter